Publications 2025

Sort by: Date | Author | Title

Gehr, N. L., Mortensen, C., Stage, T. B., Pedersen, M. R. V., Rafaelsen, S. R., Madsen, J. S., Olsen, D. A., Timm, S., Jensen, L. H., Hansen, T. F., Finnerup, N. B. & Ventzel, L. (2025). Neurofilament light chain as a marker for neuronal damage: integrating in vitro studies and clinical findings in patients with oxaliplatin-induced neuropathy. Cancer Chemotherapy and Pharmacology, 95(1), Article 53. https://doi.org/10.1007/s00280-025-04773-w
Allmendinger, F., Rosner, J., Egger, T., Scheuren, P. S. & Hubli, M. (2025). Nocebo Effect on Pain-Related Autonomic Responses in a State of Experimentally-Induced Sensitization. European journal of pain (London, England), 29(5), Article e70029. https://doi.org/10.1002/ejp.70029
Soliman, N., Moisset, X., Ferraro, M. C., de Andrade, D. C., Baron, R., Belton, J., Bennett, D. L. H., Calvo, M., Dougherty, P., Gilron, I., Hietaharju, A. J., Hosomi, K., Kamerman, P. R., Kemp, H., Enax-Krumova, E. K., McNicol, E., Price, T. J., Raja, S. N., Rice, A. S. C. ... Haroutounian, S. (2025). Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysis. The Lancet Neurology, 24(5), 413-428. https://doi.org/10.1016/S1474-4422(25)00068-7
Bitsch Poulsen, M., Okdahl, T., Buciek, J. H., Drewes, A. M., Karlsson, P., Ahluwalia, T. S., Brock, B., Brock, C., Rossing, P. & Hansen, C. S. (2025). Protocol for the FibroCAN study: a randomised controlled trial of finerenone treatment for early-stage cardiovascular autonomic neuropathy in type 2 diabetes. BMJ Open, 15(10), Article e101074. https://doi.org/10.1136/bmjopen-2025-101074
Määttä, L. L., Andersen, S. T., Parkner, T., Hviid, C. V. B., Witte, D. R., John, J., Pascal, M. M. V., Ferris, E., Baskozos, G., Ramirez, J. D., Tesfaye, S., Shillo, P. R., Rice, A. S. C., Laycock, H. C., Jensen, T. S., Bennett, D. L. & Themistocleous, A. C. (2025). Serum Neurofilament Light Chain and Structural and Functional Nerve Fiber Loss in Painful and Painless Diabetic Polyneuropathy. Diabetes Research and Clinical Practice, 223, Article 112098. https://doi.org/10.1016/j.diabres.2025.112098
Nochi, Z., Pia, H., Bloms-Funke, P., Boesl, I., Caspani, O., Chapman, S. C., Di Pietro, G., Fardo, F., Genser, B., Goetz, M., Jiang, B., Kostenko, A. V., Lebrun, L., Leone, C. M., Li, T., Möller-Grell, N., Mouraux, A., Pelz, B., Pogatzki-Zahn, E. ... Finnerup, N. B. (2025). The effects of lacosamide, pregabalin, and tapentadol on peripheral nerve excitability: A randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects. Anesthesiology, 142(5), 1279-1295. https://doi.org/10.1097/ALN.0000000000005694
Savelieff, M. G., Elafros, M. A., Viswanathan, V., Jensen, T. S., Bennett, D. L. & Feldman, E. L. (2025). The global and regional burden of diabetic peripheral neuropathy. Nature Reviews Neurology, 21(1), 17-31. Article e209652. https://doi.org/10.1038/s41582-024-01041-y